CD36 and metabolic dysfunction-associated steatotic liver disease: By influencing lipid metabolism, CD36 can accelerate the development of chronic inflammation and fibrosis in nonalcoholic fatty liver disease; microRNA-29 can halt these effects by suppressing the expression of CD36 (Lin et al., 2019).